Characteristics of patients with sulphonurea-induced hypoglycemia.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of the American Medical Directors Association

• Publication date

  2012-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jamda.2010.07.014PMID 21450199
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diabetes and Cardiovascular Disease: Is intensive glucose control beneficial or deadly? Lessons from ACCORD, ADVANCE, VADT, UKPDS, PROactive, and NICE-SUGAR

  2010cited by this paper
• Impaired Liver Glucose Production in a Murine Model of Steatosis and Endotoxemia: Protection by Inducible Nitric Oxide Synthase

  2010cited by this paper
• Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy

  2009cited by this paper
• Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A Consensus Statement of the American Diabetes Association and the European Association for the Study of Diabetes

  2009cited by this paper
• Status of diabetes management in the nursing home setting in 2008: a retrospective chart review and epidemiology study of diabetic nursing home residents and nursing home initiatives in diabetes management.

  2009cited by this paper
• Drug-Induced Hypoglycemia: A Systematic Review

  2009cited by this paper
• Glucose control and vascular complications in veterans with type 2 diabetes.

  2009cited by this paper
• Hypoglycemia and Clinical Outcomes in Patients With Diabetes Hospitalized in the General Ward

  2009cited by this paper
• Early endotoxemia increases peripheral and hepatic insulin sensitivity in healthy humans.

  2009cited by this paper
• Glycemic Control in Type 2 Diabetes: Time for an Evidence-Based About-Face?

  2009cited by this paper
• Frequency of hypoglycemia and its significance in chronic kidney disease.

  2009cited by this paper
• Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline.

  2009cited by this paper
• Intensive glycemic control in the intensive care unit: promises and pitfalls.

  2009cited by this paper
• Hypoglycemia and Clinical Outcomes in Patients With Diabetes Hospitalized in the General Ward

  2009cited by this paper
• Effects of Intensive Glucose Lowering in Type 2 Diabetes

  2009cited by this paper
• Glucose control and vascular complications in veterans with type 2 diabetes

  2009cited by this paper
• Increased risk of CKD among type 2 diabetics with nonalcoholic fatty liver disease.

  2008cited by this paper
• Effects of intensive glucose lowering in type 2 diabetes.

  2008cited by this paper
• Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

  2008cited by this paper
• Managing diabetes in the elderly: go easy, individualize.

  2008cited by this paper
• Which hypoglycaemic agents to use in type 2 diabetic subjects with CKD and how?

  2008cited by this paper
• NAFLD and hyperinsulinemia are major determinants of serum ferritin levels.

  2007cited by this paper
• Ferritin, metabolic syndrome and NAFLD: elective attractions and dangerous liaisons.

  2007cited by this paper
• Systematic Review: Comparative Effectiveness and Safety of Oral Medications for Type 2 Diabetes Mellitus

  2007cited by this paper
• Infection-related hypoglycemia in institutionalized demented patients: a comparative study of diabetic and nondiabetic patients.

  2007cited by this paper
• A Systematic Review and Meta-Analysis of Hypoglycemia and Cardiovascular Events

  2007cited by this paper
• Association between CYP2C9 slow metabolizer genotypes and severe hypoglycaemia on medication with sulphonylurea hypoglycaemic agents.

  2005cited by this paper
• Enhancement of blood glucose lowering effect of a sulfonylurea when coadministered with an ACE inhibitor: results of a glucose‐clamp study

  2005cited by this paper
• Inhibition of hepatic gluconeogenesis and enhanced glucose uptake contribute to the development of hypoglycemia in mice bearing interleukin-1beta- secreting tumor.

  2004cited by this paper
• Reviews: Use of Insulin and Oral Hypoglycemic Medications in Patients with Diabetes Mellitus and Advanced Kidney Disease

  2004cited by this paper
• Drug-induced severe hypoglycaemia in Type 2 diabetic patients aged 80 years or older.

  2004cited by this paper
• Clinical characterisation of severe hypoglycaemia--a prospective population-based study.

  2003cited by this paper
• Characteristics and time course of severe glimepiride- versus glibenclamide-induced hypoglycaemia

  2003cited by this paper
• HYPOGLYCEMIA IN PATIENTS WITH RENAL FAILURE

  2000cited by this paper
• Antihypertensive drug therapy and hypoglycemia in elderly diabetic patients treated with insulin and/or sulfonylureas

  1999cited by this paper
• Drug-induced hypoglycemic coma in 102 diabetic patients.

  1999cited by this paper
• Sulphonylurea‐induced hypoglycaemia in type 2 diabetes mellitus: a review

  1999cited by this paper
• Association between antihypertensive drug use and hypoglycemia: a case-control study of diabetic users of insulin or sulfonylureas.

  1999cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

  1998cited by this paper
• Malnutrition in patients with end-stage renal disease: diagnosis, pathophysiology and treatment.

  1997cited by this paper
• Chronic propranolol administration impairs glucagon release during insulin-induced hypoglycemia in normal man.

  1984cited by this paper
• Can insulin-treated diabetics be given beta-adrenergic blocking drugs?

  1980cited by this paper
• Aspirin Stimulates Insulin and Glucagon Secretion and Increases Glucose Tolerance in Normal and Diabetic Subjects

  1978cited by this paper

• Glycemic variability and cardiovascular disease in patients with type 2 diabetes

  2021cites this paper
• Factors associated with prolonged length of stay in patients admitted with severe hypoglycaemia to a tertiary care hospital

  2019cites this paper
• Diabetes Management in Older Adults With Chronic Kidney Disease

  2019cites this paper
• Risk of hypoglycaemia in people aged ≥65 years receiving linagliptin: pooled data from 1489 individuals with type 2 diabetes mellitus

  2018cites this paper
• Risk of severe hypoglycemia in sulfonylurea‐treated patients from diabetes centers in Germany/Austria: How big is the problem? Which patients are at risk?

  2016cites this paper
• Update on the treatment of type 2 diabetes mellitus.

  2016cites this paper
• Higher Risk of Sulfonylurea-associated Hypoglycemic Symptoms in Women with Type 2 Diabetes Mellitus

  2015cites this paper
• Linagliptin for the treatment of type 2 diabetes mellitus: a drug safety evaluation

  2015cites this paper
• Glycemic management in ESRD and earlier stages of CKD.

  2014cites this paper
• Temporal patterns of hypoglycaemia and burden of sulfonylurea-related hypoglycaemia in UK hospitals: a retrospective multicentre audit of hospitalised patients with diabetes

  2014cites this paper
• The Clinical Course of Patients with Type 2 Diabetes Presenting to the Hospital with Sulfonylurea-Induced Hypoglycemia

  2014cites this paper
• Avoiding hypoglycemia: a key to success for glucose-lowering therapy in type 2 diabetes

  2013cites this paper
• Hypoglycaemia in Type 2 Diabetes and in Elderly People

  2013cites this paper
• Rates and risk of hospitalisation among patients with type 2 diabetes: retrospective cohort study using the UK General Practice Research Database linked to English Hospital Episode Statistics

  2013cites this paper
• Diabetes management in the kidney patient.

  2013cites this paper
• Delirium in the nursing home.

  2013cites this paper
• Linagliptin for patients aged 70 years or older with type 2 diabetes inadequately controlled with common antidiabetes treatments: a randomised, double-blind, placebo-controlled trial.

  2013cites this paper
• Pharmacokinetic considerations for the treatment of diabetes in patients with chronic kidney disease

  2013cites this paper
• Jatrogena hipoglikemija u oboljelih od šećerne bolesti tipa 2 – podcijenjen problem

  2013cites this paper
• Drug-induced hypoglycaemia in type 2 diabetes

  2012cites this paper
• Utilisation des antidiabetiques oraux en cas d'insuffisance renale.

  2012cites this paper
• Adverse Drug Events as a Cause of Hospitalization in Older Adults

  2012cites this paper
• CYP2C metabolism of oral antidiabetic drugs - impact on pharmacokinetics, drug interactions and pharmacogenetic aspects

  2012cites this paper
• Clinical update on nursing home medicine: 2011.

  2011cites this paper